At the news
? BEARISHIMPACT 6/10 PRESS-RELEASE filed May 5, 2026 at 16:01 ET
Ultragenyx reported Q1 2026 revenue of $136M (consensus $158.4M) and EPS of -$1.84 (consensus -$1.46), both missing expectations. Despite reaffirming full-year 2026 guidance of $730M-$760M revenue, the weak quarter and wider operating loss of $305M signal near-term headwinds, though upcoming PDUFA dates for DTX401 and UX111 provide potential catalysts.
- Q1 2026 revenue $136M, down 2.2% YoY from $139M, missing consensus $158.4M
- Q1 2026 EPS -$1.84 vs consensus -$1.46; net loss $185M vs $151M YoY
- Reaffirmed full-year 2026 revenue guidance $730M-$760M and expense guidance
- R&D expenses $187M, up from $166M YoY; SG&A $88M flat
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access